Evidence map›Paper›PMID 42283691›Full record

ArticleAntimicrobial agents and chemotherapy2026

Selective targeting of

Sadat Shafi, Preeti Maurya, Ruby Bansal, Jyoti Sharma, Sai Kumar Mishra, Abul Kalam Najmi, Shailja Singh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sadat ShafiDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.ORCID 0000-0001-5286-6605
Preeti MauryaSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
Ruby BansalSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
Jyoti SharmaSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.
Sai Kumar MishraLife Science Research Centre, University of Ostrava, Ostrava, Czech Republic.
Abul Kalam NajmiDepartment of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.ORCID 0000-0002-9299-414X
Shailja SinghSpecial Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.ORCID 0000-0001-5286-6605

Funding

Department of Biotechnology , Ministry of Science and Technology IC-12044(11)/10/2021-ICD-DBTIndian Council of Medical Research 45/48/2019-PHA/BMSIndian Council of Medical Research NER/84/2022-ECD-I
6 · The paper itself

Abstract

The emergence of resistance to first-line antimalarial therapies highlights the critical need for next-generation drugs that target distinct molecular pathways and employ novel mechanisms of action. Notably, the intra-erythrocytic parasite development is highly dependent on a sustained glucose supply as their fundamental energy source. Therefore, exploiting a "selective starvation" strategy by targeting the parasite's reliance on glucose metabolism, particularly through the

Indexed as

AntimalarialsGinsenosidesGlucoseMonosaccharide Transport ProteinsPlasmodium falciparumAnimalsArtemisininsMalaria, FalciparumMiceMolecular Docking SimulationPlasmodium bergheiAntimalarialsartemisininArtemisininsginsenoside Rg1GinsenosidesGlucoseMonosaccharide Transport Proteinsdrug resistanceGinsenoside Rg1glucose transportermalariaPlasmodium falciparum

Identifiers

PMID42283691
PMCPMC13321806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.